Episealer® Knee technology to be presented at European scientific congress
Episurf Medical (Nasdaq: EPIS B) today announces that the Episealer® Knee technology will be presented at the ESSKA Speciality Days (European Society for Sports Traumatology, Knee Surgery and Arthroscopy) in Warsaw, Poland, on November 24-25, 2023. The presentation is a part of the scientific program within the session “Personalized small implants: When biology has failed”. The presentation will be held by Prof. Karl Eriksson from Stockholm South Hospital and The Karolinska Institute, Stockholm, Sweden.
“The ESSKA Speciality Days is one of the most important meetings for us next year, where the majority of the most prominent European orthopedic surgeons with a special interest in joint preserving surgeries will meet. We are very proud that the ESSKA organisation has appointed one of their board members to cover this topic, which clearly indicates their interest in the Episealer® technology”, says Pål Ryfors, CEO, Episurf Medical AB.
For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com
About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.
Tags: